Intranasal Vaccination with Recombinant P6 Protein and Adamantylamide Dipeptide as Mucosal Adjuvant Confers Efficient Protection against Otitis Media and Lung Infection by NontypeableHaemophilus influenzae
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.